Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: A systematic study of tolerability and use in different diagnostic groups

International Journal of Geriatric Psychiatry

Volumn 20, Issue 9, 2005, Pages 842-847

  Curran, Stephen ^a,b   Turner, Debbie ^b   Musa, Shabir ^b   Wattis, John ^a,b  

^a UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^b SOUTH WEST YORKSHIRE PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antipsychotics; BPSD; CSM; Mental illness; Older people; Psychotropics; Risperidone

Indexed keywords

AMISULPRIDE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DROPERIDOL; FLUPENTIXOL; HALOPERIDOL; HYPNOTIC SEDATIVE AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL;

AGED; ANTICHOLINERGIC EFFECT; ARTICLE; DEMENTIA; DOSE RESPONSE; DROWSINESS; DRUG SAFETY; DRUG TOLERABILITY; ENDOCRINE DISEASE; GERIATRIC CARE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MENTAL DISEASE; MOOD DISORDER; NATIONAL HEALTH SERVICE; PREVALENCE; SCHIZOPHRENIA; SIDE EFFECT; STATISTICAL SIGNIFICANCE; UNITED KINGDOM;

AFFECTIVE DISORDERS, PSYCHOTIC; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; DEMENTIA; DRUG UTILIZATION; ENGLAND; HUMANS; MENTAL DISORDERS; PSYCHOTROPIC DRUGS; RISPERIDONE;

EID: 25444513136     PISSN: 08856230     EISSN: None     Source Type: Journal    
DOI: 10.1002/gps.1365     Document Type: Article

References (14)

1. Alexopoulos GS, Streim J, Carpenter D, Docherty JP, Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients. 2004. Using antipsychotic agents in older patients. J Clin Psychiatr 65(Suppl. 2): 5-99.
2. American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders, Third Edition (Revised), APA: Washington, DC.
3. British Medical Association, Royal Pharmaceutical Society of Great Britain. 2004. British National Formulary. BMA, RPS: London; 179-183 (No 47).
4. de Hert M, Bussels, J, Lindstrom E, Abrahams F, Fransens C, Peuskens J. 1999. PECC Psychosis Evaluation Tool for Common use by Caregivers. Drukkerji EPO: Berchem.
5. Duff G, Chairman-Committee on Safety of Medicines. Accessed 02 July 2004. Atypical antipsychotic drugs and stroke. http://medicines.mhra.gov.uk/aboutagency/regframework/csm/csmhome.htm
6. Gill SS, Rochon PA, Herrmann N, et al. 2005. Atypical antipsychotics drugs and risk of ischaemic stroke: population based retrospective cohort study. Br Med J, doi:10.1136/bmj.38330.470486.8F.
7. Herrmann N, Mamdani M, Lanctot KL. 2004. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 161: 1113-1115.
8. Jeste DV, Lacro JP, Bailey A, Rockwell E, Haris MJ, Caligiuri MP. 1999. Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients. J Am Geriatr Soc 47: 716-719.
9. Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA. 2004. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. Br Med J, doi:10.1136/bmj.38125.465579.55.
10. Lindstrom E, Ekselius I, Jedenius E, Almqvist A, Wieselgren IM. 1997. A checklist for assessment of treatment in schizophrenia syndromes; interscale validity and interrater reliability. Primary Care Psychiatry 3: 183-187.
11. Mowat D, Fowlie D, MacEwan T. 2004. CSM warning on atypical psychotics and stroke may be detrimental for dementia. Br Med J 328: 1262.
12. Wirshing WC. 2001. Movement disorders associated with neuroleptic treatment. J Clin Psychiatry 62(Suppl. 21): 15-18.
13. Wooltorton E. 2002. Risperidone (Risperdal): increased incidence of cerebrovascular events in dementia trials. Can Med Assoc J 167: 1269-1270.
14. Wooltorton E. 2004. Olanzapine (Zyprexa): increased incidence of cerebrovascular events in dementia trials. Can Med Assoc J 170: 1395.